메뉴 건너뛰기




Volumn 16, Issue 2, 2013, Pages 345-355

Understanding the costs of care for cystic fibrosis: An analysis by age and health state

Author keywords

Australia; cost of illness; cystic fibrosis; registry data

Indexed keywords

ARTICLE; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; HEALTH CARE COST; HEALTH STATUS; HOSPITAL PATIENT; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MEDICAL SERVICE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

EID: 84875451063     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.12.003     Document Type: Article
Times cited : (75)

References (34)
  • 2
    • 70349231224 scopus 로고    scopus 로고
    • The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009
    • J.D. Christie, L.B. Edwards, and P. Aurora The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009 J Heart Lung Transplant 28 2009 1031 1049
    • (2009) J Heart Lung Transplant , vol.28 , pp. 1031-1049
    • Christie, J.D.1    Edwards, L.B.2    Aurora, P.3
  • 3
    • 70349251605 scopus 로고    scopus 로고
    • Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Lung and Heart/Lung Transplantation Report-2009
    • P. Aurora, L.B. Edwards, and J.D. Christie Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Lung and Heart/Lung Transplantation Report-2009 J Heart Lung Transplant 28 2009 1023 1030
    • (2009) J Heart Lung Transplant , vol.28 , pp. 1023-1030
    • Aurora, P.1    Edwards, L.B.2    Christie, J.D.3
  • 4
    • 0141924565 scopus 로고    scopus 로고
    • Cystic fibrosis: Cost of illness and considerations for the economic evaluation of potential therapies
    • C. Krauth, N. Jalilvand, and T. Welte Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies Pharmacoeconomics 21 2003 1001
    • (2003) Pharmacoeconomics , vol.21 , pp. 1001
    • Krauth, C.1    Jalilvand, N.2    Welte, T.3
  • 5
    • 0026693732 scopus 로고
    • A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients
    • M. Robson, J. Abbott, and K. Webb A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients Thorax 47 1992 684 689
    • (1992) Thorax , vol.47 , pp. 684-689
    • Robson, M.1    Abbott, J.2    Webb, K.3
  • 6
    • 0029869223 scopus 로고    scopus 로고
    • Cost of care of patients with cystic fibrosis in the Netherlands in 1990-1
    • M.F. Wildhagen, J.B. Verheij, and J.G. Verzijl Cost of care of patients with cystic fibrosis in the Netherlands in 1990-1 Thorax 51 1996 298 301
    • (1996) Thorax , vol.51 , pp. 298-301
    • Wildhagen, M.F.1    Verheij, J.B.2    Verzijl, J.G.3
  • 7
    • 0030743267 scopus 로고    scopus 로고
    • Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993
    • H.T. Ireys, G.F. Anderson, and T.J. Shaffer Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993 Pediatrics 100 1997 197 204
    • (1997) Pediatrics , vol.100 , pp. 197-204
    • Ireys, H.T.1    Anderson, G.F.2    Shaffer, T.J.3
  • 8
    • 0038309274 scopus 로고    scopus 로고
    • Cost of care and clinical condition in paediatric cystic fibrosis patients
    • U. Baumann, C. Stocklossa, and W. Greiner Cost of care and clinical condition in paediatric cystic fibrosis patients J Cys Fibros 2 2003 84 90
    • (2003) J Cys Fibros , vol.2 , pp. 84-90
    • Baumann, U.1    Stocklossa, C.2    Greiner, W.3
  • 9
    • 0032879408 scopus 로고    scopus 로고
    • Cost of care for individuals with cystic fibrosis: A regression approach to determining the impact of recombinant human dnase
    • J.A. Johnson, M.A. Connolly, and P. Jacobs Cost of care for individuals with cystic fibrosis: a regression approach to determining the impact of recombinant human dnase Pharmacotherapy 19 1999 1159 1166
    • (1999) Pharmacotherapy , vol.19 , pp. 1159-1166
    • Johnson, J.A.1    Connolly, M.A.2    Jacobs, P.3
  • 10
    • 85044704751 scopus 로고    scopus 로고
    • The cost of medical care for patients with cystic fibrosis in a health maintenance organization
    • T. Lieu, G. Ray, and G. Farmer The cost of medical care for patients with cystic fibrosis in a health maintenance organization Pediatrics 103 1999 e72
    • (1999) Pediatrics , vol.103 , pp. 72
    • Lieu, T.1    Ray, G.2    Farmer, G.3
  • 11
    • 84865042017 scopus 로고    scopus 로고
    • Cost of illness of cystic fibrosis in Germany: Results from a large cystic fibrosis centre
    • M. Heimeshoff, H. Hollmeyer, and J. Schreyogg Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre Pharmacoeconomics 30 2012 763 777
    • (2012) Pharmacoeconomics , vol.30 , pp. 763-777
    • Heimeshoff, M.1    Hollmeyer, H.2    Schreyogg, J.3
  • 12
    • 33750330561 scopus 로고    scopus 로고
    • Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France
    • V. Horvais, S. Touzet, and S. Francois Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France Int J Technol Assess Health Care 22 2006 525 531
    • (2006) Int J Technol Assess Health Care , vol.22 , pp. 525-531
    • Horvais, V.1    Touzet, S.2    Francois, S.3
  • 13
  • 14
    • 84858688407 scopus 로고    scopus 로고
    • Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: Analysis of data collected alongside a 48-week multicenter clinical trial
    • E.M. DeWitt, C.A. Grussemeyer, and JlY Friedman Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial Value Health 15 2012 277 283
    • (2012) Value Health , vol.15 , pp. 277-283
    • Dewitt, E.M.1    Grussemeyer, C.A.2    Friedman, J.3
  • 15
    • 84875432032 scopus 로고    scopus 로고
    • Australian Cystic Fibrosis Data Registry Information Management Policy and Practices. Sydney: Cystic Fibrosis Australia
    • Cystic Fibrosis Australia. Australian Cystic Fibrosis Data Registry Information Management Policy and Practices. Sydney: Cystic Fibrosis Australia, 2005.
    • (2005) Cystic Fibrosis Australia
  • 16
    • 84875452268 scopus 로고    scopus 로고
    • Cystic Fibrosis in Australia 2007: 10th Annual Report from the Australian Cystic Fibrosis Data Registry. Sydney: Cystic Fibrosis Australia
    • Cystic Fibrosis Australia. Cystic Fibrosis in Australia 2007: 10th Annual Report from the Australian Cystic Fibrosis Data Registry. Sydney: Cystic Fibrosis Australia, 2009.
    • (2009) Cystic Fibrosis Australia
  • 17
    • 0033606777 scopus 로고    scopus 로고
    • Genetic testing for cystic fibrosis [National Institutes of Health Consensus Development Conference on Genetic Testing for Cystic Fibrosis]
    • Arch Intern Med
    • NIH Consensus Development Panel on Genetic Testing for Cystic Fibrosis. Genetic testing for cystic fibrosis [National Institutes of Health Consensus Development Conference on Genetic Testing for Cystic Fibrosis]. Arch Intern Med 1999;159:1529-39.
    • (1999) NIH Consensus Development Panel on Genetic Testing for Cystic Fibrosis , vol.159 , pp. 1529-1539
  • 18
    • 0036521234 scopus 로고    scopus 로고
    • An economic evaluation of lung transplantation
    • discussion 18-20
    • Anyanwu AC, McGuire A, Rogers CA, et al. An economic evaluation of lung transplantation. J Thorac Cardiovasc Surg 2002;123:411-418; discussion 18-20.
    • (2002) J Thorac Cardiovasc Surg , vol.123 , pp. 411-418
    • Anyanwu, A.C.1    McGuire, A.2    Rogers, C.A.3
  • 19
    • 68349141120 scopus 로고    scopus 로고
    • The half-cycle correction: Banish rather than explain it
    • J.J. Barendregt The half-cycle correction: banish rather than explain it Med Decis Making 29 2009 500 502
    • (2009) Med Decis Making , vol.29 , pp. 500-502
    • Barendregt, J.J.1
  • 22
    • 84855802966 scopus 로고    scopus 로고
    • DOHA Canberra: Australian Department of Health and Ageing
    • DOHA. Pharmaceutical Benefits Schedule. Canberra: Australian Department of Health and Ageing, 2009.
    • (2009) Pharmaceutical Benefits Schedule
  • 24
    • 76249103428 scopus 로고    scopus 로고
    • Variability in the rate of prescription and cost of domiciliary oxygen therapy in Australia
    • J.G. Serginson, I.A. Yang, and J.G. Armstrong Variability in the rate of prescription and cost of domiciliary oxygen therapy in Australia Med J Aust 191 2009 549 553
    • (2009) Med J Aust , vol.191 , pp. 549-553
    • Serginson, J.G.1    Yang, I.A.2    Armstrong, J.G.3
  • 25
    • 2342637160 scopus 로고    scopus 로고
    • A randomised trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases
    • J.M. Wolter, R.A. Cagney, and J.G. McCormack A randomised trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases J Infect 48 2004 263 268
    • (2004) J Infect , vol.48 , pp. 263-268
    • Wolter, J.M.1    Cagney, R.A.2    McCormack, J.G.3
  • 26
    • 84875452174 scopus 로고    scopus 로고
    • Online store. 2010
    • Cystic Fibrosis NSW. Online store. 2010;2010.
    • (2010) Cystic Fibrosis NSW
  • 27
    • 84875416494 scopus 로고    scopus 로고
    • Government of Western Australia Perth: Department of Treasury and Finance
    • Government of Western Australia. Price Schedule - WA Government. Perth: Department of Treasury and Finance, 2007.
    • (2007) Price Schedule - WA Government
  • 29
    • 84875412808 scopus 로고    scopus 로고
    • ABS. 6401.0 - Consumer Price Index, Australia. Canberra: Australian Bureau of Statistics, 2010
    • ABS. 6401.0 - Consumer Price Index, Australia. Canberra: Australian Bureau of Statistics, 2010.
  • 31
    • 84155172438 scopus 로고    scopus 로고
    • Cystic Fibrosis Foundation Bethesda, MD: Cystic Fibrosis Foundation
    • Cystic Fibrosis Foundation. Patient Registry Annual Data Report 2009. Bethesda, MD: Cystic Fibrosis Foundation, 2011.
    • (2011) Patient Registry Annual Data Report 2009
  • 33
    • 80455144623 scopus 로고    scopus 로고
    • Therapy for cystic fibrosis: The end of the beginning?
    • P.B. Davis Therapy for cystic fibrosis: the end of the beginning? N Engl J Med 365 2011 1734 1735
    • (2011) N Engl J Med , vol.365 , pp. 1734-1735
    • Davis, P.B.1
  • 34
    • 80455162465 scopus 로고    scopus 로고
    • A CFTR potentiator in patients with cystic fibrosis and the g551d mutation
    • B.W. Ramsey, J. Davies, and N.G. McElvaney A CFTR potentiator in patients with cystic fibrosis and the g551d mutation N Engl J Med 365 2011 1663 1672
    • (2011) N Engl J Med , vol.365 , pp. 1663-1672
    • Ramsey, B.W.1    Davies, J.2    McElvaney, N.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.